Impact of metastasectomy on progression free and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry.
Margaret Meagher(University of California San Diego), Ithaar Derweesh(Rush University Medical Center), Francesco Porpiglia(University of Turin), Ricardo Autorino(Virginia Commonwealth University Medical Center), Estefanía Linares(Hospital Universitario La Paz), Matthias Heck(TUM Klinikum), Michele Marchioni(University of Chieti-Pescara), Riccardo Campi(University of Florence), Maximilian C. Kriegmair(University Medical Centre Mannheim), José Rubio(Fundación Instituto Valenciano de Oncología), Georgi Guruli(VCU Massey Comprehensive Cancer Center), Siska Van Bruwaene(AZ Groeninge), Mireía Musquera(Surgical Specialties (Canada)), Alessandro Antonelli(University of Verona), Nicola Pavan(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Fadi Ghali(University of California San Diego), E. Rousel(University of California San Diego), Alessandro Veccia(University of Verona), Andrea Mari(Azienda Ospedaliero-Universitaria Careggi), Maria Carmen Mir(Fundación Instituto Valenciano de Oncología)
Cited by 1
Related Papers
Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
|European Urology|2014|297
Urology practice during the COVID-19 pandemic
|Minerva Urologica e Nefrologica|2020|256
Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?
|European Urology|2020|207
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives
|Diagnostics|2021|158
Robot-assisted Kidney Transplantation: The European Experience
|European Urology|2017|143